3种细胞周期蛋白依赖性激酶4/6抑制剂在激素受体阳性/HER-2阴性乳腺癌中的疗效和安全性分析
于世元, 邓嘉诚, 王磊, 孙旭, 李朦, 李响, 张熠, 史若彤, 吕铮
Efficacy and safety analysis of three cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive/HER-2-negative breast cancer
Shiyuan Yu, Jiacheng Deng, Lei Wang, Xu Sun, Meng Li, Xiang Li, Yi Zhang, Ruotong Shi, Zheng Lyu
中华乳腺病杂志(电子版)
.
2026, (04): 219
-227
.
DOI: 10.3877/cma.j.issn.1674-0807.2026.04.004
